anesthesia and tirzepatide Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment Quality Improvement (SPAQI) multidisciplinary consensus statement do you need to stop

December 17th, 2024: Danish studies link Ozempic to doubled risk of rare vision loss condition Novo Nordisks Ozempic is facing scrutiny after two Danish studies found a potential link between the diabetes drug and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition causing vision loss due to reduced blood flow to the optic nerve

By activating GLP-1, GIP, and glucagon receptors, it offers a superior approach to glycemic control and substantial weight loss

LifeMD is a membership-based platform, meaning only paying members can access LifeMD services

Who may be at higher risk for a Zepbound Blindness Lawsuit

The mission is simple: better education, clearer health conversations and more practical tools for people navigating cannabis, medications, supplements and integrated wellness